Peptides boost skin firmness, leaving it visibly smoother and more resilient
These could include symptoms such as itching, a rash/hives, swelling especially around the face or throat, or difficulty breathing
The FDA approved it in 2017 for diabetes but not for weight loss
Weeks 13 through 16: 8 mg weekly
The adverse events associated with GLP-1RA are predominantly GI, particularly nausea, vomiting, and diarrhea, and occur in 1050% of patients in clinical trials (Table 2) (94)
8.2 Lactation Under current FDA labeling, the Lactation subsection may include the following elements when applicable: Risk Summary The lactation risk summary may describe: Whether the medication is present in human milk Whether the medication affects the breastfed child Whether the medication affects milk production Relevant human or animal lactation data, if available When human lactation data are available, FDA labeling gives priority to human data over animal data